Clinical Trial Update: Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating divalproex sodium for children with autism spectrum disorders and epileptiform EEG was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• DIVALPROEX SODIUM (divalproex sodium)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Autism | Phase 2 | Status: WITHDRAWN